Companies riding the wave of tuck-in acquisitions.

While the chances are relatively low that the Total Joints Market will see a tsunami-size merger in 2024 that would materially change the market landscape, SmartTRAK expects to see a ripple effect from companies that continue to seek out mergers and acquisition (M&A) deals despite the challenging economic climate. Since the beginning of 2023, deals that had a more subtle effect on the market include those providing expanded international reach or initial entrance into the market. In this downloadable article, SmartTRAK highlights the acquisitions taking place since the beginning of 2023 and outlines the sentiment of some of the major companies towards future M&A. SmartTRAK also looks at what may be coming for the top Total Joints Market players, including Zimmer Biomet, Stryker, J&J/DePuy Synthes and Smith+Nephew, as they continue riding the wave of tuck-in acquisitions ...

Just click the button below to read the complete "M&A in the Total Joints Market" perspective article written by Lisa Mahan, SmartTRAK VP Product Development & IT, Sr. Analyst Total Joints.

---

SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK offers and how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.

Forces likely to influence the Total Joints Market in 2024

Final Q423 US Total Joints Market results are expected to solidify above pre-COVID growth rates for 2023. The post-pandemic patient backlog sustained strong market performance in 2023 despite tough comparisons and a challenging economic environment with rising inflation and the threat of a recession looming over healthcare consumers. What will the future hold? In this article, SmartTRAK looks at some of the trends to watch in 2024, including:

• Mixed Predictions Regarding Patient Backlog
  Several Companies including Zimmer Biomet are banking on the backlog of patients to continue boosting procedure growth through 2024. Wall Street analysts, however, are more tempered in their forward-looking projections.
• US Economic Factors Buoying Consumer Confidence
  The demand for health care is typically more resilient in the face of weaker economic conditions. However, improvements in some economic conditions in the US during 2024 are expected to buoy consumer confidence.
  
• Ongoing Shift to Outpatient Site-of-Care Despite Reimbursement Decline
  Eligible patients are continuing to choose joint replacement surgery in an outpatient or ambulatory surgery center (ASC) setting in increasing numbers. New ASCs springing up around the country are giving potential patients expanded site-of-care options.
• Ongoing Influence of ASC Economics
  ASCs facing lower reimbursement rates compared to hospital outpatient and inpatient settings will continue to look for product solutions that improve efficiency and reduce the overall cost of care.
  
• New Product Launches to Watch
  New and early-stage hip and knee product launches for both large and mid-tier Joint Replacement Market players will drive revenue growth.
  
  

Just click the button below to download and read the complete "Total Joints 2024 Trends to Watch" market outlook article and analysis by Lisa Mahan, SmartTRAK's VP Product Development & IT, Sr. Analyst TJ&E.

---

SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK offers and how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.

Increased elective procedure volume recovery lifts market growth to new heights

The winds of change precipitated a strong season of growth for the Total Joints Market. Company after company reported increasing elective procedural volume recovery due to the underlying post-COVID demand. Procedure momentum and easier year-over-year comparisons drove market growth above double-digits with the US Total Joints Market growing +14.5% in Q123. Easing of staffing headwinds and normalization of surgery cancellation rates were also contributing factors to accelerating procedures.

 

AAOS approaches “Next to Normal” as surgeons and industry focus on solutions to meet the needs of patients returning to joint replacement

If an ad agency had branded the American Academy of Orthopedic Surgeons (AAOS) 2023 Annual Meeting this year, the tagline would have read “Getting back to normal.” Surgeons toured the exhibit hall throughout the day not just during dedicated hours. The meeting felt as if it had come back to life with industry symposiums and conference presentations often seeing standing-room-only crowds when a few years ago even the exhibit floor felt like a ghost town. And while some of the large orthopedic companies slightly scaled down their booth space, several mid-tier and small market players increased their presence at the meeting in an attempt to pique surgeon interest. So what was the buzz at AAOS 2023 related to hip and knee replacement? In this article, SmartTRAK outlines some of the key takeaways, including: 

• Procedure Recovery May Signal Return of Deferred Procedures
  • Both clinicians and company representatives at the meeting revealed to SmartTRAK that they are seeing increased hip and knee procedure volumes heading into 2023. The overall consensus was ...
    
    
• The Move to Outpatient Joint Replacement Continues.
  • Data presented at AAOS 2023 continues to support the move of joint replacement surgeries to an outpatient setting. A study focusing on patient satisfaction after outpatient joint replacement in an academic medical center reported ...
    
    
• Cementless Knee Trend Growing Despite Mixed Results
  • Clinical evidence presented at AAOS showed mixed results for cementless total knees with some studies reporting excellent outcomes and others identifying increased risks associated with ...
    
    
• Assistive Technologies Growing and Evolving
  • Assistive technology presentations and booth exhibits seemed to generate the most interest at AAOS 2023. Elise Wolf, SmartTRAK’s assistive technologies expert, noted the most innovative products and ...
    
    

To download and read the complete "AAOS 2023: Total Joint Viewpoint" article by SmartTRAK's Lisa Mahan,  VP Product Development & IT, Sr. Analyst TJ&E, just click the button below.

Procedure recovery above Q4 seasonality, new products and assistive tech push strong revenue growth

  For Q422, the US Hip Replacement Market grew +8.4% according to SmartTRAK Financial Dashboard . Newer products, implant pull-through from assistive technologies and procedure recovery continued to positively impact growth. Nearly all companies in our reporting universe cited procedure recovery as a growth driver.

 

The US Knee Replacement Market grew +9.3% in Q422, driven in part by knee procedure recovery. Recovery appeared to be above that of the typical year-end seasonality of patients trying to fit in surgery before insurance deductibles reset. SmartTRAK has heard rumblings that the growth seen in Q4 may be a sign that ...

 

To read more about the strong revenue growth in the Total Joints Market, including Procedure Recovery, New Products and Assistive Technologies Driving Growth in the Hip Market and Cementless Knees and Enabling Tech Expanding the Knee Market, just click the link below.

Read the entire Q422 Total Joints Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*  

 

* This link and the complete unedited article can only be viewed by SmartTRAK  subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please  click  the button below.

SmartTRAK examines conditions lowering the flame for Total Joints

 

An analyst from JP Morgan has  drawn  parallels between the current behavior of the US stock and bond markets and the conditions leading up to the 1969 recession, according to a recent  Forbes  article. Interest rate hikes and high inflation have increased the likelihood that the US economy will face a recession in 2023. But what does that mean for the Total Joints Market?